Academic Content and Language Evaluation of This Article
CrossCheck and Google Search of This Article
Academic Rules and Norms of This Article
Citation of this article
Corresponding Author of This Article
Research Domain of This Article
Article-Type of This Article
Open-Access Policy of This Article
Times Cited Counts in Google of This Article
Number of Hits and Downloads for This Article
- Total Article Views (6059)
All Articles published online
|
Featured Article
|
Publishing Process of This Article
|
Oct 15, 2022 (publication date) through Dec 27, 2024
Times Cited of This Article
Journal Information of This Article
Publication Name
World Journal of Diabetes
ISSN
1948-9358
Publisher of This Article
Baishideng Publishing Group Inc, 7041 Koll Center Parkway, Suite 160, Pleasanton, CA 94566, USA
| For: | Nagy G, Szekely TE, Somogyi A, Herold M, Herold Z. New therapeutic approaches for type 1 diabetes: Disease-modifying therapies. World J Diabetes 2022; 13(10): 835-850 [PMID: 36312000 DOI: 10.4239/wjd.v13.i10.835] |
|---|---|
| URL: | https://www.wjgnet.com/1948-0210/full/v13/i10/835.htm |
| Number | Citing Articles |
| 1 |
Sunetra Mondal, Joseph M Pappachan. Current perspectives and the future of disease-modifying therapies in type 1 diabetes. World Journal of Diabetes 2025; 16(1): 99496 doi: 10.4239/wjd.v16.i1.99496
Abstract(78) |
Core Tip(72) |
Full Article(HTML)(366)
|
Full Article with Cover (PDF)-12141K(12)
|
Audio-684K(1)
|
Peer-Review Report-234K(7)
|
Answering Reviewers-48K(7)
|
Supplementary Material-74K(9)
|
Full Article (PDF)-11580K(24)
|
Full Article (XML)-162K(9)
|
Times Cited (0)
|
Total Visits (974)
|
Open
|
| 2 |
Xiao-Lan Ma, Dan Ge, Xue-Jian Hu. Evaluation of teplizumab's efficacy and safety in treatment of type 1 diabetes mellitus: A systematic review and meta-analysis. World Journal of Diabetes 2024; 15(7): 1615-1626 doi: 10.4239/wjd.v15.i7.1615
|
| 3 |
Bantayehu Addis Tegegne, Adane Adugna, Aderaw Yenet, Wubetu Yihunie Belay, Yared Yibeltal, Abebe Dagne, Zigale Hibstu Teffera, Gashaw Azanaw Amare, Desalegn Abebaw, Haymanot Tewabe, Rahel Belete Abebe, Tirsit Ketsela Zeleke. A critical review on diabetes mellitus type 1 and type 2 management approaches: from lifestyle modification to current and novel targets and therapeutic agents. Frontiers in Endocrinology 2024; 15 doi: 10.3389/fendo.2024.1440456
|
| 4 |
Jason Seewoodhary, Angela Silveira. Teplizumab – preventative approaches to type 1 diabetes mellitus. Practical Diabetes 2023; 40(2): 35 doi: 10.1002/pdi.2448
|
| 5 |
Diletta Maria Francesca Ingrosso, Maria Teresa Quarta, Alessia Quarta, Francesco Chiarelli. Prevention of Type 1 Diabetes in Children: A Worthy Challenge?. International Journal of Environmental Research and Public Health 2023; 20(11): 5962 doi: 10.3390/ijerph20115962
|
| 6 |
Rossana Caldara, Valentina Tomajer, Paolo Monti, Valeria Sordi, Antonio Citro, Raniero Chimienti, Chiara Gremizzi, Davide Catarinella, Stefano Tentori, Vera Paloschi, Raffella Melzi, Alessia Mercalli, Rita Nano, Paola Magistretti, Stefano Partelli, Lorenzo Piemonti. Allo Beta Cell transplantation: specific features, unanswered questions, and immunological challenge. Frontiers in Immunology 2023; 14 doi: 10.3389/fimmu.2023.1323439
|
| 7 |
Sagnik Nag, Oishi Mitra, Bhanu Maturi, Simran Preet Kaur, Ankita Saini, Muskan Nama, Soumik Roy, Souvik Samanta, Leena Chacko, Rohan Dutta, Suresh Babu Sayana, Vetriselvan Subramaniyan, Jasvinder Singh Bhatti, Ramesh Kandimalla. Autophagy and mitophagy as potential therapeutic targets in diabetic heart condition: Harnessing the power of nanotheranostics. Asian Journal of Pharmaceutical Sciences 2024; 19(3): 100927 doi: 10.1016/j.ajps.2024.100927
|
| 8 |
Dragica Mićanović, Suzana Stanisavljević, Hanluo Li, Ivan Koprivica, Natalija Jonić, Ivana Stojanović, Vuk Savković, Tamara Saksida. Mesenchymal Stem Cells from Mouse Hair Follicles Inhibit the Development of Type 1 Diabetes. International Journal of Molecular Sciences 2024; 25(11): 5974 doi: 10.3390/ijms25115974
|
| 9 |
Mingshu Huang, Weixing Chen, Min Wang, Yisheng Huang, Hongyu Liu, Yue Ming, Yuanxin Chen, Zhengming Tang, Bo Jia. Advanced Delivery Strategies for Immunotherapy in Type I Diabetes Mellitus. BioDrugs 2023; 37(3): 331 doi: 10.1007/s40259-023-00594-6
|
| 10 |
Yu.V. Bykov. Prevention of type 1 diabetes mellitus in children and adolescents. Profilakticheskaya meditsina 2024; 27(1): 115 doi: 10.17116/profmed202427011115
|
| 11 |
Dirk Müller-Wieland, Martin Miszon, Désirée Dunstheimer, Thomas Forst, Thomas Michael Kapellen, Oliver Schnell, Monika Kellerer. C-Peptid als Surrogatparameter einer residualen Beta-Zellfunktion bei Typ-1-Diabetes und ihre mögliche klinische Bedeutung. Diabetologie und Stoffwechsel 2024; 19(06): 433 doi: 10.1055/a-2377-7108
|